Quantification of pituitary 5-HT1B receptors with positron emission tomography: Negligible specific binding despite conspicuous uptake.

While Positron Emission Tomography (PET) images with the 5-HT1B receptor specific radioligand [11C]AZ10419369 show pronounced uptake in the pituitary region, and experimental studies support 5-HT1B receptor involvement in pituitary hormonal release, this uptake remains unquantified. In the present study we applied invasive and non-invasive models to evaluate pituitary 5-HT1B receptor binding. Ten subjects underwent PET with [11C]AZ10419369, of which six participated in three additional PET-examinations after pretreatment with increasing doses of the 5-HT1B receptor antagonist AZD3783. While [11C]AZ10419369 binding in the brain displayed dose-dependent reductions after AZD3783, no dose-dependent inhibition of binding was observed for the pituitary. Distribution volume ratios were plotted against occupancy values to graphically estimate regional differences in non-displaceable binding, thereby allowing for estimation of BPND in extracerebral regions. Using this method, baseline pituitary BPND appears to be negligible, implying that most of the pituitary [11C]AZ10419369 uptake is comprised of free or nonspecifically bound radioligand. Our findings highlight potential pitfalls when assuming that conspicuous regional radioligand uptake indicates presence of specific binding.

• Publication year

  2026

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2026-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0271678X261417194PMID 41656562PMCID PMC12885964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlook

  2025cited by this paper
• Serotonin transporter availability increases in patients recovering from a depressive episode

  2021cited by this paper
• Kinfitr — an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability

  2020cited by this paper
• A local-neighborhood Lassen plot filter for creating occupancy and non-displaceable binding images

  2020cited by this paper
• A Survey of Molecular Imaging of Opioid Receptors

  2019cited by this paper
• Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain

  2019cited by this paper
• Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans

  2019cited by this paper
• The 5-HT1B receptor - a potential target for antidepressant treatment

  2018cited by this paper
• Is Migraine Primarily a Metaboloendocrine Disorder?

  2018cited by this paper
• MRI evaluation of size and shape of normal pituitary gland: Age and sex related changes

  2017cited by this paper
• Radiosynthesis and evaluation of 1-substituted 3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-(3R,6R)-2,5-piperazinedione derivatives as PET tracers for imaging the central oxytocinergic system.

  2017cited by this paper
• Revisiting the Logan plot to account for non-negligible blood volume in brain tissue

  2017cited by this paper
• Radioligand binding analysis of α2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding

  2017cited by this paper
• Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder.

  2016cited by this paper
• PET imaging evaluation of [18F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates

  2016cited by this paper
• Guidelines to PET measurements of the target occupancy in the brain for drug development

  2016cited by this paper
• The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential

  2015cited by this paper
• Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue model.

  2015cited by this paper
• New therapeutic approaches for the prevention and treatment of migraine.

  2015cited by this paper
• Test–retest reliability of [11C]AZ10419369 binding to 5-HT1B receptors in human brain

  2014cited by this paper
• Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain

  2014cited by this paper
• ABC transporter-dependent brain uptake of the 5-HT1B receptor radioligand [11C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig

  2014cited by this paper
• The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactin

  2013cited by this paper
• Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.

  2013cited by this paper
• Normative database of the serotonergic system in healthy subjects using multi-tracer PET

  2012cited by this paper
• Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT

  2012cited by this paper
• Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist

  2011cited by this paper
• Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369

  2011cited by this paper
• Quantitative Analysis of [11C]AZ10419369 Binding to 5-HT1B Receptors in Human Brain

  2011cited by this paper
• Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.

  2010cited by this paper
• Kinetic Modeling of the Serotonin 5-HT1B Receptor Radioligand [11C]P943 in Humans

  2010cited by this paper
• [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain

  2008cited by this paper
• Novel Reference Region Model Reveals Increased Microglial and Reduced Vascular Binding of 11C-(R)-PK11195 in Patients with Alzheimer's Disease

  2008cited by this paper
• The circumventricular organs: an atlas of comparative anatomy and vascularization.

  2007cited by this paper
• Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors.

  2007cited by this paper
• Effect of monoamine oxidase inhibition on amphetamine‐evoked changes in dopamine receptor availability in the living pig: A dual tracer PET study with [11C]harmine and [11C]raclopride

  2006cited by this paper
• Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

  2004cited by this paper
• Hypothalamic involvement in chronic migraine

  2001cited by this paper
• Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743.

  2001cited by this paper
• Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans

  2001cited by this paper
• Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain

  1999cited by this paper
• Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?

  1999cited by this paper
• The spectrum of behaviors influenced by serotonin.

  1998cited by this paper
• Simplified reference tissue model for PET receptor studies.

  1996cited by this paper
• Blood supply, blood flow and autoregulation in the adenohypophysis, and altered patterns in oestrogen-induced adenomatous hyperplasia.

  1995cited by this paper
• Neuroendocrine probes of serotonergic function: a critical review.

  1993cited by this paper
• Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.

  1990cited by this paper
• Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis

  1989cited by this paper
• Regional neurohypophyseal blood flow and its control in adult sheep.

  1981cited by this paper

• No citing papers are available for this paper.